MedPacto, Inc. (KOSDAQ:235980)
6,120.00
-220.00 (-3.47%)
Jan 19, 2026, 3:30 PM KST
MedPacto Market Cap
MedPacto has a market cap or net worth of 209.76 billion as of January 16, 2026. Its market cap has increased by 32.91% in one year.
Market Cap
209.76B
Enterprise Value
168.22B
Revenue
2.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,120.00
Market Cap Chart
Since December 19, 2019, MedPacto's market cap has decreased from 362.50B to 209.76B, a decrease of -42.13%. That is a compound annual growth rate of -8.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 217.30B | -5.09% |
| Dec 30, 2025 | 228.96B | 50.62% |
| Dec 30, 2024 | 152.01B | -37.48% |
| Dec 28, 2023 | 243.12B | -48.17% |
| Dec 29, 2022 | 469.05B | -60.97% |
| Dec 30, 2021 | 1.20T | -49.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 90.13T |
| Celltrion | 45.73T |
| ALTEOGEN | 27.70T |
| ABL Bio | 10.89T |
| SK Biopharmaceuticals | 9.43T |
| Yuhan | 8.05T |
| HLB Co., Ltd. | 6.97T |
| Sam Chun Dang Pharm. | 6.49T |